By Metro US
Posted on
RIO DE JANEIRO (Reuters) – Pfizer has not yet applied for emergency use of its COVID-19 vaccine in Brazil, health regulator Anvisa said on Thursday, adding that the company has not yet provided enough data for the vaccine to be used locally.
Anvisa added in its statement that no vaccine producer has yet applied for a definitive registration or for emergency use of a COVID-19 vaccine in Brazil.
(Reporting by Gabriel Stargardter; Editing by Brad Haynes)
NFL to open academy in Australia to identify and develop young prospects
Anze Kopitar scores in overtime, Kings beat Oilers 5-4 in Game 2 to tie series
Defending champion Golden Knights beat Stars 3-1 to take 2-0 series lead home to Vegas
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Hungary’s Orbán urges European conservatives, and Trump, toward election victories at CPAC event
Ukraine is putting pressure on fighting-age men outside the country as it tries to replenish forces
The Latest | Israeli strikes in Rafah kill at least 5 as ship comes under attack in the Gulf of Aden
Colleges turn to police to quell pro-Palestinian protests ahead of graduation ceremonies
Family of American man believed to be held by Taliban asks the UN torture investigator for help
Tough new EPA rules would force coal-fired power plants to capture emissions or shut down
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
